These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15124024)

  • 1. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease.
    Akilesh S; Petkova S; Sproule TJ; Shaffer DJ; Christianson GJ; Roopenian D
    J Clin Invest; 2004 May; 113(9):1328-33. PubMed ID: 15124024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.
    Petkova SB; Akilesh S; Sproule TJ; Christianson GJ; Al Khabbaz H; Brown AC; Presta LG; Meng YG; Roopenian DC
    Int Immunol; 2006 Dec; 18(12):1759-69. PubMed ID: 17077181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.
    Li N; Zhao M; Hilario-Vargas J; Prisayanh P; Warren S; Diaz LA; Roopenian DC; Liu Z
    J Clin Invest; 2005 Dec; 115(12):3440-50. PubMed ID: 16284651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
    Wang Y; Tian Z; Thirumalai D; Zhang X
    J Drug Target; 2014 May; 22(4):269-78. PubMed ID: 24404896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.
    Roopenian DC; Christianson GJ; Sproule TJ; Brown AC; Akilesh S; Jung N; Petkova S; Avanessian L; Choi EY; Shaffer DJ; Eden PA; Anderson CL
    J Immunol; 2003 Apr; 170(7):3528-33. PubMed ID: 12646614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
    Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model.
    Patel DA; Puig-Canto A; Challa DK; Perez Montoyo H; Ober RJ; Ward ES
    J Immunol; 2011 Jul; 187(2):1015-22. PubMed ID: 21690327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.
    Kim J; Bronson CL; Wani MA; Oberyszyn TM; Mohanty S; Chaudhury C; Hayton WL; Robinson JM; Anderson CL
    Exp Biol Med (Maywood); 2008 May; 233(5):603-9. PubMed ID: 18375831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice.
    Lu W; Zhao Z; Zhao Y; Yu S; Zhao Y; Fan B; Kacskovics I; Hammarström L; Li N
    Immunology; 2007 Nov; 122(3):401-8. PubMed ID: 17608809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.
    Hansen RJ; Balthasar JP
    Thromb Haemost; 2002 Dec; 88(6):898-9. PubMed ID: 12529736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Targeting of FcRn and FcγRs
    Monnet C; Jacque E; de Romeuf C; Fontayne A; Abache T; Fournier N; Dupont G; Derache D; Engrand A; Bauduin A; Terrier A; Seifert A; Beghin C; Longue A; Masiello N; Danino L; Nogre M; Raia A; Dhainaut F; Fauconnier L; Togbe D; Reitinger C; Nimmerjahn F; Stevens W; Chtourou S; Mondon P
    Front Immunol; 2021; 12():728322. PubMed ID: 34512662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.
    Sesarman A; Vidarsson G; Sitaru C
    Cell Mol Life Sci; 2010 Aug; 67(15):2533-50. PubMed ID: 20217455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.
    Smith B; Kiessling A; Lledo-Garcia R; Dixon KL; Christodoulou L; Catley MC; Atherfold P; D'Hooghe LE; Finney H; Greenslade K; Hailu H; Kevorkian L; Lightwood D; Meier C; Munro R; Qureshi O; Sarkar K; Shaw SP; Tewari R; Turner A; Tyson K; West S; Shaw S; Brennan FR
    MAbs; 2018 Oct; 10(7):1111-1130. PubMed ID: 30130439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).
    Solomon S; Kolb C; Mohanty S; Jeisy-Walder E; Preyer R; Schöllhorn V; Illges H
    Eur J Immunol; 2002 Mar; 32(3):644-51. PubMed ID: 11857338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Fc receptor and IgG-based therapeutics.
    Kuo TT; Aveson VG
    MAbs; 2011; 3(5):422-30. PubMed ID: 22048693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MHC class I-related FcRn ameliorates murine Lyme arthritis.
    Crowley H; Alroy J; Sproule TJ; Roopenian D; Huber BT
    Int Immunol; 2006 Mar; 18(3):409-14. PubMed ID: 16415101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilities.
    Tam SH; McCarthy SG; Brosnan K; Goldberg KM; Scallon BJ
    MAbs; 2013; 5(3):397-405. PubMed ID: 23549129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
    Smith B; Christodoulou L; Clargo A; Eddleston A; Greenslade K; Lightwood D; Shock A; Tyson K; Brennan FR
    Int Immunopharmacol; 2019 Jan; 66():362-365. PubMed ID: 30529500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention.
    Patel DD; Bussel JB
    J Allergy Clin Immunol; 2020 Sep; 146(3):467-478. PubMed ID: 32896307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan.
    Chaudhury C; Mehnaz S; Robinson JM; Hayton WL; Pearl DK; Roopenian DC; Anderson CL
    J Exp Med; 2003 Feb; 197(3):315-22. PubMed ID: 12566415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.